Annual Operating Expenses
$51.88 M
+$18.75 M+56.58%
December 31, 2021
Summary
- As of February 10, 2025, FSTX annual total operating expenses is $51.88 million, with the most recent change of +$18.75 million (+56.58%) on December 31, 2021.
- During the last 3 years, FSTX annual operating expenses has risen by +$5.21 million (+11.18%).
Performance
FSTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Expenses
$14.83 M
-$1.35 M-8.34%
September 30, 2022
Summary
- As of February 10, 2025, FSTX quarterly total operating expenses is $14.83 million, with the most recent change of -$1.35 million (-8.34%) on September 30, 2022.
- Over the past year, FSTX quarterly operating expenses has increased by +$4.48 million (+43.27%).
Performance
FSTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
FSTX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +56.6% | +43.3% |
| 3 y3 years | +11.2% | +125.1% |
| 5 y5 years | +11.2% | +125.1% |
FSTX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -8.3% | -11.2% |
| 5 y | 5-year | at high | -36.1% | -8.3% | -64.1% |
| alltime | all time | at high | -36.1% | -8.3% | -64.1% |
F-star Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $14.83 M(-8.3%) |
| Jun 2022 | - | $16.18 M(+17.8%) |
| Mar 2022 | - | $13.74 M(+4.3%) |
| Dec 2021 | $51.88 M | $13.18 M(+27.3%) |
| Sep 2021 | - | $10.35 M(-30.0%) |
| Jun 2021 | - | $14.79 M(+9.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $13.56 M(+57.1%) |
| Dec 2020 | $33.13 M(-29.0%) | $8.63 M(-31.4%) |
| Sep 2020 | - | $12.58 M(+136.1%) |
| Jun 2020 | - | $5.33 M(-19.1%) |
| Mar 2020 | - | $6.59 M |
| Dec 2019 | $46.67 M | - |
FAQ
- What is F-star Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for F-star Therapeutics?
- What is F-star Therapeutics annual operating expenses year-on-year change?
- What is F-star Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for F-star Therapeutics?
- What is F-star Therapeutics quarterly operating expenses year-on-year change?
What is F-star Therapeutics annual total operating expenses?
The current annual operating expenses of FSTX is $51.88 M
What is the all time high annual operating expenses for F-star Therapeutics?
F-star Therapeutics all-time high annual total operating expenses is $51.88 M
What is F-star Therapeutics annual operating expenses year-on-year change?
Over the past year, FSTX annual total operating expenses has changed by +$18.75 M (+56.58%)
What is F-star Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of FSTX is $14.83 M
What is the all time high quarterly operating expenses for F-star Therapeutics?
F-star Therapeutics all-time high quarterly total operating expenses is $16.18 M
What is F-star Therapeutics quarterly operating expenses year-on-year change?
Over the past year, FSTX quarterly total operating expenses has changed by +$4.48 M (+43.27%)